USPTO serial 88390036
TAKE CONTROL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- BEN, LINDSEY HEATHER
- Law office
- TMEG LAW OFFICE 108 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with TAKE CONTROL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael J. Leonard
MICHAEL J. LEONARD FOX ROTHSCHILD LLP997 LENOX DRIVE, BLDG. 3LAWRENCEVILLE, NJ 08648-2311UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Body care and toiletry products, namely, body, hand and facial creams, bath and skin lotions, skin moisturizers and moisturizing lotions, shampoo, hair conditioners and body wash | ACTIVE | — |
| 005 | Dietary and nutritional supplements, medicinal herbal extract, nutraceuticals for use as a dietary supplements for medical treatment of pain, pain relief medication; Homeopathic supplements, topical preparations in the nature of creams, gels and sprays for medical treatment of pain, pain relief medication; topical preparations for use in treating skin maladies, namely, dermatitis and skin pigmentation diseases, fungal skin infections and skin irritations, namely, rashes, sores, corns, calluses and acne; Medical marijuana, medical cannabis, strains of cannabis sativa for the treatment of metabolic diseases and disorders, namely, diabetes, type II diabetes, nephropathy, inflammation of the intestine, neuroinflammatory disorders, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, bulimia nervosa, anorexia, obesity and hypothyroidism, obesity associated with diabetes, and for the treatment of pain, neuropathic pain, neurogenic pain, cancer pain, peri-operative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, MS spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, and Doose syndrome, bladder dysfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory connective tissue diseases, arthritis, neurodegenerative diseases, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, cerebral palsy, brain, movement, ocular motility, peripheral neuropathy, neurogenic symptoms, hypoxicischemic encephalopathy, neonatal hypoxic encephalopathy, stroke, motion sickness and chemically induced sickness, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse, autism, nausea, vomiting, loss of appetite, muscle tension, muscle spasms, epilepsy, glaucoma, arthritis, Parkinson's disease, gastrointestinal illness, anxiety, bi-polar disorder, depression, insomnia, and for topical treatment of skin inflammation, namely, eczema, psoriasis, atopic dermatitis, acne, rosacea, lichen planus, bullous pemphigold, vasculitis, granuloma annulare and erythroderma; Cannabinoid capsules for use as a dietary food supplement; tetrahydrocannabinol capsules for use as a dietary food supplement; cannabidiol capsules for use as a dietary food supplement; Cannabinoid oil for use as a dietary food supplement; tetrahydrocannabinol oil for use as a dietary food supplement; cannabidiol oil for use as a dietary food supplement; Transdermal patches containing cannabinoids, tetrahydrocannabinol and cannabidiol for the treatment of metabolic diseases and disorders, namely, diabetes, type II diabetes, nephropathy, inflammation of the intestine, neuroinflammatory disorders, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, bulimia nervosa, anorexia, obesity and hypothyroidism, obesity associated with diabetes, and for the treatment of pain, neuropathic pain, neurogenic pain, cancer pain, peri-operative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, MS spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, and Doose syndrome, bladder dysfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory connective tissue diseases, arthritis, neurodegenerative diseases, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, cerebral palsy, brain, movement, ocular motility, peripheral neuropathy, neurogenic symptoms, hypoxicischemic encephalopathy, neonatal hypoxic encephalopathy, stroke, motion sickness and chemically induced sickness, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse, autism, nausea, vomiting, loss of appetite, muscle tension, muscle spasms, epilepsy, glaucoma, arthritis, Parkinson's disease, gastrointestinal illness, anxiety, bi-polar disorder, depression, insomnia, and for topical treatment of skin inflammation, namely, eczema, psoriasis, atopic dermatitis, acne, rosacea, lichen planus, bullous pemphigold, vasculitis, granuloma annulare and erythroderma; Botanical, herbal, nutraceutical, dietary and nutritional supplements for general health and well-being; botanical, herbal, nutraceutical, dietary and nutritional preparations and botanical, herbal, nutraceutical, dietary and nutritional substances containing plant extracts and plant-derived nutrients to reduce stress and fatigue, increase appetite, reduce anxiety, relax tension, mood enhancement and provide an improved sense of well-being; Pharmaceutical and nutraceutical preparations and pharmaceutical and nutraceutical substances containing plant extracts and plant-derived ingredients for the treatment of metabolic diseases and disorders, namely, diabetes, type II diabetes, nephropathy, inflammation of the intestine, neuroinflammatory disorders, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, bulimia nervosa, anorexia, obesity and hypothyroidism, obesity associated with diabetes, and for the treatment of pain, neuropathic pain, neurogenic pain, cancer pain, peri-operative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, MS spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, and Doose syndrome, bladder disfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory connective tissue diseases, arthritis, neurodegenerative diseases, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, cerebral palsy, brain, movement, ocular motility, peripheral neuropathy, neurogenic symptoms, hypoxicischemic encephalopathy, neonatal hypoxic encephalopathy, stroke, motion sickness and chemically induced sickness, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse, autism, nausea, vomiting, loss of appetite, muscle tension, muscle spasms, epilepsy, glaucoma, arthritis, Parkinson's disease, gastrointestinal illness, anxiety, bi-polar disorder, depression, insomnia, and for topical treatment of skin inflammation, namely, eczema, psoriasis, atopic dermatitis, acne, rosacea, lichen planus, bullous pemphigold, vasculitis, granuloma annulare and erythroderma; medicinal herbs, medicinal oils, and medicinal infusions for treating metabolic diseases and disorders, namely, diabetes, type II diabetes, nephropathy, inflammation of the intestine, neuroinflammatory disorders, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, bulimia nervosa, anorexia, obesity and hypothyroidism, obesity associated with diabetes, and for the treatment of pain, neuropathic pain, neurogenic pain, cancer pain, peri-operative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, MS spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, and Doose syndrome, bladder disfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory connective tissue diseases, arthritis, neurodegenerative diseases, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, cerebral palsy, brain, movement, ocular motility, peripheral neuropathy, neurogenic symptoms, hypoxicischemic encephalopathy, neonatal hypoxic encephalopathy, stroke, motion sickness and chemically induced sickness, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse, autism, nausea, vomiting, loss of appetite, muscle tension, muscle spasms, epilepsy, glaucoma, arthritis, Parkinson's disease, gastrointestinal illness, anxiety, bi-polar disorder, depression, insomnia, and for topical treatment of skin inflammation, namely, eczema, psoriasis, atopic dermatitis, acne, rosacea, lichen planus, bullous pemphigold, vasculitis, granuloma annulare and erythroderma; appetite suppressants for medical purpose; Veterinary preparations for the treatment of long-term neurogenic pain, muscle spasms, muscle cramps, reduced appetite, weight loss, and vomiting in livestock animals, farm animals, pet animals, and domestic animals; veterinary preparations, namely, pain relief medication; pharmaceutical and veterinary preparations for the treatment of pain and the induction of sedation, anxiety relief, and pain relief during therapeutic and diagnostic procedures; Diagnostic preparations and reagents for medical laboratory use; Pre-filled drug dispensing inhalers used by patients which can record and transmit medical data associated with the drug management process to physicians; topical creams, gels, salves, sprays, balms and ointments for analgesic purposes | ACTIVE | — |
| 032 | Non-alcoholic hemp and hemp-based beverages | ACTIVE | — |
| 034 | Electric vaporizers, namely, smokeless vaporizer pipes for the ingestion and inhalation of tobacco and marijuana; nicotine-based liquid, namely, liquid nicotine used to refill electronic cigarettes; cartridges sold filled with liquid nicotine for electronic cigarettes; electronic cigarette refill liquids, namely, chemical flavorings in liquid form used to refill electronic cigarettes and oral vaporizers; cartridges sold filled with chemical flavorings in liquid form for electronic cigarettes and oral vaporizers; electronic cigarettes; electronic smoking vaporizers, namely, electronic cigarettes; tobacco substitutes in liquid solution form for electronic cigarettes; refill cartridges sold empty for electronic cigarettes and oral vaporizers; electric vaporizers, namely, smokeless vaporizer pipes for the ingestion and inhalation of tobacco and marijuana; processed tobacco pods; pipe tobacco, namely, tobacco for use in electric vaporizers; tobacco, whether manufactured or unmanufactured; smoking tobacco, pipe tobacco, hand rolling tobacco, snus tobacco; tobacco sold in pods; smoker's articles, namely, filter tubes, cigarette papers, matches, and lighters; Paraphernalia for smoking, namely, rolling papers, vaporizers, diffusers, grinders, smoking pipes; Dried flower marijuana; dried marijuana; Marijuana pods for use in oral vaporizers e-cigarettes and smoking pipes; Pre-rolled marijuana cigarettes; Cannabinoid oils for use in oral vaporizers, e-cigarettes and smoking pipes; Capsules containing cannabinoids, tetrahydrocannabinol and cannabidiol for use with oral vaporizers, e-cigarettes and smoking pipes; friable puck of compressed dried marijuana for smoking and vaping purposes | ACTIVE | — |
| 035 | Retail sale of cannabis and cannabis based products, dietary and nutritional supplements, pharmaceutical preparations, veterinary preparations, food and beverages, cosmetics, body care and toiletry products and clothing accessible on-line and by telephone, facsimile and mail order; online sales of cannabis and cannabis based products, dietary and nutritional supplements, pharmaceutical preparations, veterinary preparations, food and beverages, cosmetics, body care and toiletry products and clothing; Wholesaler distributorship in the field of cannabis and cannabis based products, dietary and nutritional supplements, pharmaceutical preparations, veterinary preparations, food and beverages, cosmetics, body care and toiletry products and clothing | ACTIVE | — |
| 044 | Providing a website featuring online publications, namely, articles in the nature of medical issues relating to the cannabis industry; providing horticultural information about strains and effects of cannabis; Dispensing of medications and pharmaceuticals; Medical analysis, diagnosis and testing of patients for the treatment of disease using marijuana; veterinary services; Horticultural services, namely, cultivation, breeding, production, processing, distribution, transportation and retail sale of natural plants and flowers, living plants, plant cuttings, agricultural seeds, dried plants, hemp, hemp seeds, herbs for medical purposes; Providing medical information relating to the preparation and dispensing of medications; Medical counselling relating to the use of marijuana as a treatment for illness; Providing rating information, reviews and recommendations on medical marijuana products posted by online users via a website | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Emerald Health Intellectual Property, Inc.
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 032
- Other trademarks in Class 034
- Other trademarks in Class 035
- Other trademarks in Class 044
- Similar marks named TAKE CONTROL
- Prosecution event MAB2 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 21, 2020 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 21, 2020 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Feb 6, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 6, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 6, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 3, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| May 21, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 21, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 19, 2019 | ALIE | ASSIGNED TO LIE | — |
| May 14, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| May 11, 2019 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| May 3, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 20, 2019 | NWAP | NEW APPLICATION ENTERED | — |